The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis

[1]  P. Rüegsegger,et al.  Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography , 2004, European Journal of Clinical Pharmacology.

[2]  R. Laan,et al.  Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content , 2004, Calcified Tissue International.

[3]  Pharmd,et al.  Prednisone-induced bone loss , 2002 .

[4]  G. Fitzmaurice,et al.  Effects of inhaled glucocorticoids on bone density in premenopausal women. , 2001, The New England journal of medicine.

[5]  C. Cooper,et al.  Public health impact of adverse bone effects of oral corticosteroids. , 2001, British journal of clinical pharmacology.

[6]  V. Naganathan,et al.  Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. , 2001, The Journal of rheumatology.

[7]  R. Hubbard,et al.  Adverse effects of oral corticosteroids in relation to dose in patients with lung disease , 2001, Thorax.

[8]  G. Berntsen,et al.  Forearm bone mineral density by age in 7,620 men and women: the Tromsø study, a population-based study. , 2001, American journal of epidemiology.

[9]  J. Jamart,et al.  Primary Prevention of Glucocorticoid‐Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1‐Year Study Comparing a Single Infusion, an Infusion Given Once Every 3 Months, and Calcium Alone , 2001, Journal of Bone and Mineral Research.

[10]  M. Hochberg,et al.  Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update: American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis , 2001 .

[11]  C. Cooper,et al.  Comparison of Calcaneal Ultrasound and DXA to Assess the Risk of Corticosteroid-Induced Osteoporosis: A Cross-sectional Study , 2001, Osteoporosis International.

[12]  T. Fujita,et al.  Oral Glucocorticoid-Induced Fall in Cortical Bone Volume and Density in Postmenopausal Asthmatic Patients , 2001, Osteoporosis International.

[13]  C. Cooper,et al.  Use of Inhaled Corticosteroids and Risk of Fractures , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  C. Cooper,et al.  Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. , 2000, Rheumatology.

[15]  V. Naganathan,et al.  Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. , 2000, Archives of internal medicine.

[16]  L Abenhaim,et al.  The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results , 2000, Pharmacoepidemiology and drug safety.

[17]  W. Blackwelder,et al.  Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. , 2000, The Journal of rheumatology.

[18]  R. Weinstein,et al.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. , 2000, The Journal of clinical endocrinology and metabolism.

[19]  S. Manolagas.  Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  P. Selby,et al.  Corticosteroids Do Not Alter the Threshold for Vertebral Fracture , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  J. Nolla,et al.  Estudio densitométrico en mujeres posmenopáusicas con artritis reumatoide tratadas con dosis bajas de glucocorticoides , 2000 .

[22]  S. Poupon,et al.  Long‐Term Corticosteroid Therapy Induces Mild Changes in Trabecular Bone Texture , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  F. Houssiau,et al.  Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. , 2000, Rheumatology.

[24]  M. Davie,et al.  Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men , 2000, Annals of the rheumatic diseases.

[25]  T. Fujita,et al.  Acute Alteration in Bone Mineral Density and Biochemical Markers for Bone Metabolism in Nephrotic Patients Receiving High-Dose Glucocorticoid and One-Cycle Etidronate Therapy , 2000, Calcified Tissue International.

[26]  S. Laurberg,et al.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis , 2000, Gut.

[27]  G. Haugeberg,et al.  No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids. , 2000, Scandinavian journal of rheumatology.

[28]  J. Teichmann,et al.  Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica – a prospective study on the influence of glucocorticoid therapy , 2000, Zeitschrift für Rheumatologie.

[29]  P. Roberson,et al.  Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. , 1999, The Journal of clinical investigation.

[30]  R. Honkanen,et al.  Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study. , 1999, American journal of respiratory and critical care medicine.

[31]  T. Inoue,et al.  Effects of glucocorticoids on bone mineral density in rheumatoid arthritis patients , 1999, Archives of Orthopaedic and Trauma Surgery.

[32]  C. Cooper,et al.  A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update , 1998, Journal of internal medicine.

[33]  J. Hopper,et al.  Bone Mineral Density and Bone Turnover in Asthmatics Treated with Long‐Term Inhaled or Oral Glucocorticoids , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[35]  E. Lau,et al.  Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. , 1998, British journal of rheumatology.

[36]  C. Mcevoy,et al.  Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[37]  P. Delmas,et al.  The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica. , 1998, British journal of rheumatology.

[38]  H. Wahner,et al.  Updated Data on Proximal Femur Bone Mineral Levels of US Adults , 1998, Osteoporosis International.

[39]  G. Panayi,et al.  Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. , 1997, Arthritis and rheumatism.

[40]  R. Buchbinder,et al.  Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. , 1997, The Journal of rheumatology.

[41]  J. Jamart,et al.  Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intermittent Intravenous Pamidronate: A Randomized Trial , 1997, Calcified Tissue International.

[42]  Jacques P. Brown,et al.  Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. , 1997, The New England journal of medicine.

[43]  J. Kelsey,et al.  Risk Factors for Hip Fracture in Men , 1997 .

[44]  D. Reid,et al.  Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. , 1997, British journal of rheumatology.

[45]  O Johnell,et al.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. , 1996, BMJ.

[46]  D. Chappard,et al.  Altered trabecular architecture induced by Corticosteroids: A Bone Histomorphometric Study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  D. Mancini,et al.  Fracture after cardiac transplantation: a prospective longitudinal study. , 1996, The Journal of clinical endocrinology and metabolism.

[48]  F. Houssiau,et al.  Trabecular and cortical bone loss in systemic lupus erythematosus. , 1996, British journal of rheumatology.

[49]  E. Barrett-Connor,et al.  Inhaled and oral corticosteroids: their effects on bone mineral density in older adults. , 1995, American journal of public health.

[50]  R. Eastell,et al.  Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.

[51]  J. Setoain,et al.  The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. , 1995, British journal of rheumatology.

[52]  J. Nolla,et al.  Sex hormone status and bone mineral density in men with rheumatoid arthritis. , 1995, The Journal of rheumatology.

[53]  W. Lems,et al.  Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. , 1995, Clinical and experimental rheumatology.

[54]  J. Nolla,et al.  Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. , 1995, Annals of the rheumatic diseases.

[55]  S. Cummings,et al.  Rheumatoid arthritis and bone mineral density in elderly women , 1995 .

[56]  J. Sayre,et al.  Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  C. Cooper,et al.  Rheumatoid arthritis, corticosteroid therapy and hip fracture. , 1995, Annals of the rheumatic diseases.

[58]  J. Sibley,et al.  Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. , 1994, The Journal of rheumatology.

[59]  D. Furst,et al.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. , 1994, The American journal of medicine.

[60]  R. Honkanen,et al.  Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study. , 1994, Annals of the rheumatic diseases.

[61]  H. Wahner,et al.  The evaluation of osteoporosis : dual energy x-ray absorptiometry in clinical practice , 1994 .

[62]  S. Jessop,et al.  Loss of trabecular bone mineral density in systemic lupus erythematosus. , 1993, Arthritis and rheumatism.

[63]  P. V. van Riel,et al.  Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis , 1993, Annals of Internal Medicine.

[64]  T. Spector,et al.  The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. , 1993, Arthritis and rheumatism.

[65]  E. Shane,et al.  Osteoporosis after cardiac transplantation. , 1993, The American journal of medicine.

[66]  J. Shellito,et al.  Elevated 1,25-dihydroxyvitamin D levels in patients with chronic obstructive pulmonary disease treated with prednisone. , 1993, The Journal of clinical endocrinology and metabolism.

[67]  I. Reid,et al.  Lateral spine densitometry is a more sensitive indicator of glucocorticoid‐induced bone loss , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[68]  J. G. Douglas,et al.  Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. , 1992, Thorax.

[69]  I. Reid,et al.  Normal bone mineral density following cure of Cushing's syndrome , 1992, Clinical endocrinology.

[70]  S. Gallacher,et al.  Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. , 1992, Thorax.

[71]  P. Sambrook,et al.  Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. , 1992, British journal of rheumatology.

[72]  J. Montserrat,et al.  Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. , 1991, Thorax.

[73]  S. Silverman,et al.  Glucocorticoid-induced osteoporosis: a cross-sectional study , 1991, Steroids.

[74]  B. Julian,et al.  Rapid loss of vertebral mineral density after renal transplantation. , 1991, The New England journal of medicine.

[75]  R. Butler,et al.  Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. , 1991, British journal of rheumatology.

[76]  M. Liang,et al.  Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. , 1991, The Journal of rheumatology.

[77]  P Rüegsegger,et al.  Differential effects of aging and disease on trabecular and compact bone density of the radius. , 1991, Bone.

[78]  J. Eisman,et al.  Corticosteroid effects on proximal femur bone loss , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  I. Reid,et al.  Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. , 1990, Archives of internal medicine.

[80]  H. Pols,et al.  Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids. , 1990, Gastroenterology.

[81]  D. Isenberg,et al.  Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. , 1990, Annals of the rheumatic diseases.

[82]  D. Mellström,et al.  Osteoporosis after long‐term corticosteroid treatment of giant cell arteritis , 1990, Journal of internal medicine.

[83]  Munro,et al.  Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. , 1989, Clinical orthopaedics and related research.

[84]  G. Rizzato,et al.  Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women. , 1988, Sarcoidosis.

[85]  R. Patterson,et al.  Prevalence of adverse effects in corticosteroid dependent asthmatics. , 1988, New England and regional allergy proceedings.

[86]  R. Downs,et al.  Effect of short‐term glucocorticoids on serum osteocalcin in healthy young men , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[87]  D. Felson,et al.  ACROSS-STUDY EVALUATION OF ASSOCIATION BETWEEN STEROID DOSE AND BOLUS STEROIDS AND AVASCULAR NECROSIS OF BONE , 1987, The Lancet.

[88]  P. Tothill,et al.  Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. , 1986, British medical journal.

[89]  J. Eisman,et al.  Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. , 1986, Annals of the rheumatic diseases.

[90]  J. Dequeker,et al.  Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. , 1986, Annals of the rheumatic diseases.

[91]  S. Rashiq,et al.  Role of drugs in fractures of the femoral neck , 1986, British medical journal.

[92]  I. Reid,et al.  Low serum osteocalcin levels in glucocorticoid-treated asthmatics. , 1986, The Journal of clinical endocrinology and metabolism.

[93]  J. Compston,et al.  Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy. , 1985, Gastroenterology.

[94]  W. Murphy,et al.  Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. , 1985, Arthritis and rheumatism.

[95]  J. Devogelaer,et al.  The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry. , 1984, Advances in experimental medicine and biology.

[96]  G H Guyatt,et al.  Determining causation--a case study: adrenocorticosteroids and osteoporosis. Should the fear of inducing clinically important osteoporosis influence the decision to prescribe adrenocorticosteroids? , 1984, Journal of chronic diseases.

[97]  H. Bohr,et al.  Bone mineral in lumbar spine, femoral neck and femoral shaft measured by dual photon absorptiometry with 153-gadolineum in prednisone treatment. , 1984, Advances in experimental medicine and biology.

[98]  A. Adinoff,et al.  Steroid-induced fractures and bone loss in patients with asthma. , 1983, The New England journal of medicine.

[99]  P. Tothill,et al.  Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. , 1982, British medical journal.

[100]  B. Henderson,et al.  Menopausal estrogen therapy and hip fractures. , 1981, Annals of internal medicine.

[101]  M. Chapuy,et al.  Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis , 1979 .

[102]  P. Saville,et al.  Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. , 1967, Arthritis and rheumatism.

[103]  G. Fraser,et al.  OSTEOPOROSIS AND PURPURA IN RHEUMATOID DISEASE: PREVALENCE AND RELATION TO TREATMENT WITH CORTICOSTEROIDS , 1962 .